India’s largest power generation company, Tata Power Co. Ltd, has approved the issuance of non-convertible debentures of around Rs 1,500 crore.

SGX Nifty indicates that the markets may have a firm start this Wednesday but like Tuesday, it could face a resistance soon. The range for the day is likely to be 8,800-9,050. Until and unless Nifty does not decisively breach this range on either side, we could see it staying within the boundaries of the range mentioned.

The important support for Nifty is placed around 8,800 mark and a decisive move below this support level, could drag Nifty towards 8,550-8,500 in the short-term. On the upside, the zone of 9,050-9,120 is likely to act as a stiff resistance. Stocks in news: Finolex Industries, Mangalam Drugs and Organics, Tata Power, Spice Jet.

The shares of the mining company, Vedanta Limited, tanked more than two per cent today after the company announced that its board of directors has approved a proposal for delisting the company from BSE and NSE. 

Nesco’s consolidated revenue for the fourth quarter of FY20 was up by 25.9 per cent YoY to Rs 117.75 crore. This was primarily due to 86 per cent YoY jump in the IT Park revenue

TCS iONTM, a strategic unit of Tata Consultancy Services (TCS), announced the launch of remote assessments, a product that enables universities and exam boards to conduct secure, free and fair examinations at scale, in a remote model. The exam schedule of education institutions and exam conducting boards has been deeply impacted due to the current pandemic.

Lincoln Pharmaceuticals Limited has received European Union (EU) GMP certification from Germany FDA for its manufacturing facility located at Khatraj (Gujarat). The certification will allow the company to market its products in all the 27 member countries of EU and also give an access to European Economic Area (EEA) countries. The company aims to enter EU markets very soon with its dermatology, gastro and pain management products and gradually expand product portfolio.

Fabric manufacturer, Raymond Ltd, announced that the company is planning to raise funds via NCDs this week.

Pharma major Lupin Limited announced that it had launched an authorised generic version of Bausch Health’s Apriso (Mesalamine extended-release capsules 0.375 gm) in US Market.

Alembic Pharmaceuticals Limited informed the bourses on Tuesday that its joint venture, Aleor Dermaceuticals Limited has received approval from United States Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Clobetasol Propionate shampoo, 0.05 per cent.